Long-term effect of aripiprazole lauroxil on health-related quality of life in patients with schizophrenia

BACKGROUND: This post hoc analysis of clinical trial data evaluated long-term, self-reported mental and physical health-related quality of life (HRQoL) scores in schizophrenia patients receiving aripiprazole lauroxil (AL), an atypical long-acting injectable (LAI) antipsychotic approved for the treat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Psychiatry
Glavni autori: McEvoy, Joseph P., Weiden, Peter J., Lysaker, Paul H., Sun, Xiaowu, O’Sullivan, Amy K.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2021
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7992347/
https://ncbi.nlm.nih.gov/pubmed/33761928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-021-03124-2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items